Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Department Of Internal Medicine
Iowa City, IA 52242Phone+1 404-778-1900
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
One Brooklyn Health System - Kingsbrook Jewish Medical CenterResidency, Internal Medicine, 2009 - 2012
University of California San Francisco School of MedicinePost-Doctoral Fellowship, 2006 - 2009- Dana-Farber Cancer Institute, Harvard Medical SchoolPost-Doctoral Fellowship, 2006 - 2006
- Lousiana State University Health Science CenterPhD, Cancer Biology, Cellular Biology & Anatomy, 2000 - 2004
Hunan Medical UniversityClass of 1995
Certifications & Licensure
KS State Medical License 2019 - 2025
MO State Medical License 2021 - 2025
IA State Medical License 2015 - 2021- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy Start of enrollment: 2021 Sep 14
Publications & Presentations
PubMed
- 7 citationsIRAK-M suppresses the activation of microglial NLRP3 inflammasome and GSDMD-mediated pyroptosis through inhibiting IRAK1 phosphorylation during experimental autoimmune...Yuanyuan Wang, Shanshan Pei, Zhuhe Liu, Yuewen Ding, Tinglin Qian
Cell Death & Disease. 2023-02-10 - 1 citationsCorrigendum to 'Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer': [ESMO Open Volume 7 Issue 1 (2022) 100395].S Ren, J Wang, J Ying, T Mitsudomi, D H Lee
ESMO Open. 2022-06-01 - 53 citationsConsensus for HER2 alterations testing in non-small-cell lung cancer.S Ren, J Wang, J Ying, T Mitsudomi, D H Lee
ESMO Open. 2022-02-01
Grant Support
- A New Mouse Model of PI3-Kinase Induced Breast CancerCalifornia Breast Cancer Research Program2006–2009
Professional Memberships
- Fellow
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
